The Sickle Cell Clinical Trials Network: One Year In
The Hematologist Editor-in-Chief, Dr. Laura Michaelis, spoke with Drs. Charles Abrams and Sophie Lanzkron about a groundbreaking ASH initiative started approximate
Is Double-hit Diffuse Large B-cell Lymphoma More Common Than We Think?
Dr. Kahl studies the biologic underpinnings of a new entity that does not meet the classical definition of double-hit (DH) DLBCL but has gene expression signatures and clin
Invited opinion pieces written by leaders of the hematology community.
The information presented in the Op-Eds for The Hematologist does not necessarily represent the opinions, beliefs, or positions of The Hematologist and/or the American Society of Hematology. The Hematologist is not responsible for any errors or omissions in the materials; reliance on any information presented is solely at your own risk. The Hematologist welcomes Op-Ed pieces or letters of up to 200 words to the editor on any subject, and will publish based on editorial decisions regarding interest to readers and space availability. These Op-Eds may also be edited for reasons of space and clarity. Send your letters to Managing Editor Juana Llorens at email@example.com.
Drs. Clifford Hudis, Robert Carlson, and Roy Silverstein shed light on the importance of finding an approach to the opioid crisis that takes into account the needs of individuals who experience chronic pain as a result of hematologic conditions.
Drs. Andrea Cervi, Artemis Diamantouros, and Madeleine Verhovsek provide commentary on the implications of assigning a "hazardous drug" label to hydroxyurea.
Dr. Belinda Avalos provides an update on how the Standing Committee on Promoting Diversity is advising ASH in its efforts to improve minority recruitment into hematology research and practice in the U.S. and Canada.
Dr. George and Dr. Gullapalli provide a thorough synopsis of the history of Theranos, a medical and technological innovations laboratory company founded by Elizabeth Holmes.
Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.
Dr. Cynthia Dunbar, Dr. Janis Abkowitz, Dr. Nancy Berliner, and Dr.
Susan Shurin discuss the concerted grassroots effort to nominate women
for ASH awards.
Congresswoman Louise Slaughter discusses the provisions of the bill she sponsored that protects the privacy of patients who undergo genetic testing.
Dr. Barry Coller discusses the concept of the physician as discoverer, highlighting how this model has been eroded by changes in medical education and training and suggesting measures that can be taken to restore it.
As both a part-time hematologist and mother, Dr. Lanie Francis shares advice on achieving success and satisfaction at home and at the office.
Dr. Meir Preis explains how new standards for resident duty hours may affect the organization of inpatient teaching services.
July-August 2019Volume 16, Issue 4
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology